In this May 27, 2019, file photo, a bird flies with Mount Everest seen in the background from Namche Bajar, Solukhumbu district, Nepal. (AP Photo/Niranjan Shrestha, File)
By Binaj Gurubacharya
China and Nepal jointly announced a new official height for Mount Everest on Tuesday, ending a discrepancy between the two nations.
The new height of the world's highest peak is 8,848.86 meters (29,031.7 feet), which is slightly more than Nepal’s previous measurement and about four meters (13 feet) higher than China’s.
Chinese Foreign Minister Wang Yi and his Nepalese counterpart, Pradeep Gyawali, simultaneously pressed buttons during a virtual conference and the new height flashed on the screen.
The height of Everest, which is on the border between China and Nepal, was agreed on after surveyors from Nepal scaled the peak in 2019 and a Chinese team did the same in 2020.
There had been debate over the actual height of the peak and concern that it might have shrunk after a major earthquake in 2015. The quake killed 9,000 people, damaged about 1 million structures in Nepal and triggered an avalanche on Everest that killed 19 people at the base camp.
There was no doubt that Everest would remain the highest peak because the second highest, Mount K2, is only 8,611 meters (28,244 feet) tall.
Everest's height was first determined by a British team around 1856 as 8,842 meters (29,002) feet.
But the most accepted height has been 8,848 meters (29,028 feet), which was determined by the Survey of India in 1954.
In 1999, a National Geographic Society team using GPS technology came up with a height of 8,850 (29,035 feet). A Chinese team in 2005 said it was 8,844.43 meters (29,009 feet) because it did not include the snow cap.
A Nepal government team of climbers and surveyors scaled Everest in May 2019 and installed GPS and satellite equipment to measure the peak and snow depth on the summit.
Chinese President Xi Jinping visited Nepal later that year and the leaders of the two countries decided that they should agree on a height.
A survey team from China then conducted measurements in the spring of 2020 while all other expeditions were canceled due to the coronavirus pandemic.
Nepal's climbing community welcomed the end of confusion over the mountain's height.
“This is a milestone in mountaineering history which will finally end the debate over the height and now the world will have one number,” said Santa Bir Lama, president of the Nepal Mountaineering Association.
China's official Xinhua New Agency quoted Xi as saying the two sides are committed to jointly protecting the environment around Everest and cooperating in scientific research.
For China, the announcement appeared to be as much about politics as geography. China has drawn Nepal ever closer into its orbit with investments in its economy and the building of highways, dams, airports and other infrastructure in the impoverished nation.
That appears to serve China’s interests in reducing the influence of rival India, with which it shares a disputed border, and Nepal’s role as a destination for refugee Tibetans.
The Xinhua report said nothing about the technical aspects but heavily emphasized the joint announcement’s geopolitical weight.
China and Nepal will establish an “even closer community of a shared future to enrich the countries and their peoples,” Xinhua quoted Xi as saying.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
